Corteva Cuts 2026 Outlook as Brazil Demand Collapses, Shares Hit 52-Week Low
CTVA is trading near its 52-week low of $9.536 (14% above the low).
Summary
Corteva's Q3 missed on both lines and management slashed the full-year outlook, with CEO Luke Kissam calling Brazil 'materially weaker than anticipated.' Latin America organic sales plunged 31% on elevated inventories, delayed purchases and farmer liquidity constraints, dragging total organic sales down 9% and adjusted pro forma operating EBITDA down 17% to $222 million. The company now guides full-year adjusted pro forma operating earnings to 76-80 cents a share versus the $1.07 consensus, and EBITDA to $1.1-1.125 billion. It also expects $130-140 million of 2026 pretax restructuring charges as it streamlines Crop Protection, substantially complete by 2028. Shares were down 7.66% at $11.21 premarket, a new 52-week low, and the stock remains under a court order blocking dividends and buybacks tied to the Vylor spin-off litigation.
At the time of this announcement, CTVA was trading at $10.89 on NYSE in the Manufacturing sector, with a market capitalization of approximately $8.1B. The 52-week trading range was $9.54 to $14.62. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Benzinga.